Next Article in Journal
Modulation of Glia Activation by TRPA1 Antagonism in Preclinical Models of Migraine
Next Article in Special Issue
Subclinical Acute Kidney Injury in COVID-19: Possible Mechanisms and Future Perspectives
Previous Article in Journal
Fenbendazole Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice via Suppression of Fibroblast-to-Myofibroblast Differentiation
Previous Article in Special Issue
Lung Inflammasome Activation in SARS-CoV-2 Post-Mortem Biopsies
 
 
Article
Peer-Review Record

Alterations in the Kynurenine–Tryptophan Pathway and Lipid Dysregulation Are Preserved Features of COVID-19 in Hemodialysis

Int. J. Mol. Sci. 2022, 23(22), 14089; https://doi.org/10.3390/ijms232214089
by Max Schuller 1,†, Monika Oberhuber 2,†, Barbara Prietl 2,3, Elmar Zügner 4, Eva-Maria Prugger 4, Christoph Magnes 4, Alexander H. Kirsch 1, Sabine Schmaldienst 5, Thomas Pieber 2,3, Marianne Brodmann 6, Alexander R. Rosenkranz 1, Philipp Eller 7 and Kathrin Eller 1,*
Reviewer 1:
Reviewer 2:
Int. J. Mol. Sci. 2022, 23(22), 14089; https://doi.org/10.3390/ijms232214089
Submission received: 15 October 2022 / Revised: 7 November 2022 / Accepted: 9 November 2022 / Published: 15 November 2022
(This article belongs to the Special Issue Coronavirus Disease (COVID-19): Pathophysiology 3.0)

Round 1

Reviewer 1 Report

In this study, the authors identified metabolic alterations induced by COVID-19, particularly in the Kyn-Trp pathway and in the lipid metabolism dysregulation.

The study is well-performed and well-written. I have read your manuscript carefully and have no suggestions to contribute as the methods and results are appropriate for the objective of the study. Furthermore, the discussion discusses all possible topics that the present study shows, including the limitations of the study.

I want to congratulate all the authors for their important work in understanding the molecular mechanisms underlying the severity of COVID-19.

Author Response

We thank the Reviewer for his/her generous comments on our manuscript! 

Reviewer 2 Report

In the present study, the authors recruited 18 and nine asymptomatic/mild, 11 and 11 moderate, two and 13 severely affected, and 10 and six uninfected hemodialysis (HD) and non-HD patients to analyzed the plasma metabolites in different COVID-19 stages in patients with or without HD. The authors found Elevated kynurenine levels and lipid dysregulation, shown by an increase of circulating free fatty acids and a decrease of lysophospholipids, could distinguish patients with moderate COVID-19 from non-infected individuals in both groups. Kynurenine and lipid alterations were also associated with ICAM-1 and IL-15 levels in HD and non-HD patients.

 

1, The authors should provide Clinical characteristics and Baseline characteristics of patients. Results must be excluded if other factors are involved.

2. How did the authors divide COVID-19–positive patients into groups with asymptomatic/mild,  moderate, and severely affected patients?

3. Does the metabolism correlate with renal function?

4. The relationship between tryptophan and COVID-19 IN HEMODIALYSIS is not well represented in the article. 

Author Response

Please see the attachment!

Author Response File: Author Response.docx

Round 2

Reviewer 2 Report

This is an interesting manuscript and overall the study is well-conducted.

Back to TopTop